Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2010
09/02/2010WO2010099301A2 Piggybac transposon variants and methods of use
09/02/2010WO2010099219A2 Designer ligands of tgf-beta superfamily
09/02/2010WO2010099205A1 Methods for treating progressive multifocal leukoencephalopathy (pml)
09/02/2010WO2010099169A2 A novel in vitro hiv-1 latency model for screening reactivation agents of hiv-1
09/02/2010WO2010099153A2 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
09/02/2010WO2010099134A1 Methods for increasing starch content in plant cobs
09/02/2010WO2010099127A2 Free circulating dna bio-markers and their applications
09/02/2010WO2010099083A1 Isolated novel nucleic acid and protein molecules from soybeans and methods of using those molecules
09/02/2010WO2010099019A1 Antibodies containing therapeutic tpo/epo mimetic peptides
09/02/2010WO2010098682A1 Cell marker for melanocyte lineage and cancer cells and uses thereof
09/02/2010WO2010098670A1 Fusarium resistant cucumber plants
09/02/2010WO2010098667A1 Means and methods for durable inhibition of pathogens
09/02/2010WO2010098561A2 Novel beta-galactosidase having a high transglycosylation activity, and a use therefor
09/02/2010WO2010098505A1 Process for producing novel optically active mandelic acid and derivative thereof
09/02/2010WO2010098471A1 Immunization method using cancer cell
09/02/2010WO2010098429A1 Immunologic adjuvant composition and use thereof
09/02/2010WO2010098421A1 Recombinant human bone morphogenetic protein having improved storage stability
09/02/2010WO2010098419A1 Novel nuclear reprogramming substance
09/02/2010WO2010098378A1 Β-glucan-deficient gene in barley, synthetic gene, and use of same
09/02/2010WO2010098103A1 Equol-producing bacterium and use thereof
09/02/2010WO2010097746A1 Metallothionein gene conferring abiotic stress tolerance in plants and uses thereof
09/02/2010WO2010097623A1 Transgenic plants comprising constructs encoding phosphoenolpyruvate carboxykinase and/or pyruvate ortho phos phate dikinase
09/02/2010WO2010097589A1 Method for screening phage display libraries against each other
09/02/2010WO2010097490A1 GENOME SEQUENCES OF PRIMERS AND A PROBE FOR THE QUANTIFICATION OF PORCINE ADENOVIRUSES (PAdV)
09/02/2010WO2010097471A2 Protein targets in disease
09/02/2010WO2010097437A1 Method for producing antibodies
09/02/2010WO2010097436A1 Mutant cells having reduced expression of metallopeptidase, suitable for recombinant polypeptide production
09/02/2010WO2010097435A1 Method for producing antibodies
09/02/2010WO2010097419A1 Conditionally replicating adenovirus effective in the treatment of tumors
09/02/2010WO2010097414A1 Improved design of small-interfering rna
09/02/2010WO2010097411A1 Signal sequence-independent pix phage display
09/02/2010WO2010097388A1 Biotin-prototrophic yeasts
09/02/2010WO2010097343A1 Plants having enhanced yield-related traits and a method for making the same
09/02/2010WO2010097240A1 Expression vector system comprising two selection markers
09/02/2010WO2010097239A1 Methods for selecting eukaryotic cells expressing a heterologous protein
09/02/2010WO2010096941A1 Methods for identifying immunobinders of cell-surface antigens
09/02/2010WO2010096931A1 Novel lignin-resistant cellulase enzymes
09/02/2010WO2010096930A1 Single chain antibodies for targeting pancreatic alpha and beta cells
09/02/2010WO2010096888A1 Vaccines containing attenuated strains, method for forming attenuated strains, vaccine vectors and use thereof for the treatment of salmonellosis
09/02/2010WO2010080452A3 siRNA COMPOUNDS AND METHODS OF USE THEREOF
09/02/2010WO2010079335A9 Method for improving biomass yield
09/02/2010WO2010064897A8 Farmesene synthase
09/02/2010WO2010060099A3 Wall-associated kinase-like polypeptide mediates nutritional status perception and response
09/02/2010WO2010058298A3 Transgenic plants and fungi capable of metabolizing phosphite as a source of phosphorus
09/02/2010WO2010049817A3 Lipochito-oligosaccharides stimulating arbuscular mycorrhizal symbiosis
09/02/2010WO2010047509A9 Anti-dr5 antibody with improved affinity and stability, and composition for cancer prevention or treatment including same
09/02/2010WO2010045469A3 Muc18 targeting peptides
09/02/2010WO2010039750A3 Transgenic plants with enhanced agronomic traits
09/02/2010WO2009158464A3 Thermoactive sivagm sab reverse transcriptase
09/02/2010WO2009139921A3 Microorganisms for preventing and treating neoplasms accompanying cellular therapy
09/02/2010US20100223696 Maize Cellulose Synthases and Uses Thereof
09/02/2010US20100223695 NAC Transcriptional Activators Involved in Abiotic Stress Tolerance
09/02/2010US20100223694 Recombinant DNA Constructs and Methods for Controlling Gene Expression
09/02/2010US20100223690 Compositions and methods for modulating plant disease resistance and immunity
09/02/2010US20100223689 Plants with enhanced size and growth rate
09/02/2010US20100223688 Generation of plants with improved pathogen resistance
09/02/2010US20100223686 Mouse in which genome is modified
09/02/2010US20100223685 Il-21 receptor knockout animal and methods of use thereof
09/02/2010US20100223683 Isolated Polynucleotide Sequence with IRES Activity
09/02/2010US20100223682 Casein and methods of use thereof
09/02/2010US20100223681 Assessment Method
09/02/2010US20100223679 Targeted and regional cellular ablation in zebrafish
09/02/2010US20100222564 Methods and compositions for isolating small rna molecules
09/02/2010US20100222557 Cytokine zalpha11ligand antibodies
09/02/2010US20100222556 Antibodies to cytokine receptor zalpha11
09/02/2010US20100222553 Spider silk dragline polynucleotides, polypeptides and methods of use thereof
09/02/2010US20100222551 Highly thermostable fluorescent proteins
09/02/2010US20100222419 Method to inhibit cell growth using oligonucleotides
09/02/2010US20100222418 Combination Products For Treating Cancer
09/02/2010US20100222414 SiRNA Sequence-Independent Modification Formats for Reducing Off-Target Phenotypic Effects in RNAi, and Stabilized Forms Thereof
09/02/2010US20100222412 Modulation of glucocorticoid receptor expression
09/02/2010US20100222408 Methods and Compositions for Treatment of Cystic Fibrosis
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100222273 Modified cry35 proteins
09/02/2010US20100222267 Recombinant transferrin mutants
09/02/2010US20100222266 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
09/02/2010US20100222263 Atap peptides, nucleic acids encoding the same and associated methods of use
09/02/2010US20100222261 Peptidic antagonists of class iii semaphorins/neuropilins complexes
09/02/2010US20100222237 Methods for Generating Polynucleotides Having Desired Characteristics by Iterative Selection and Recombination
09/02/2010US20100222231 Use of antisense oligonucleotide libraries for identifying gene function
09/02/2010US20100221948 Labelling assembly
09/02/2010US20100221827 Methods for reprogramming somatic cells
09/02/2010US20100221826 INFECTIOUS cDNA CLONE OF THE MODIFIED LIVE VIRUS VACCINE STRAIN OF EQUINE ARTERITIS VIRUS
09/02/2010US20100221825 Avian cell lines useful for the production of substances of interest
09/02/2010US20100221824 Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac
09/02/2010US20100221822 Humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/02/2010US20100221821 Methods and compositions related to riboswitches that control alternative splicing and rna processing
09/02/2010US20100221820 Use of triplex structure DNA in transferring nucleotide sequences
09/02/2010US20100221813 Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria
09/02/2010US20100221812 Production of genetically modified actinomycetes by recombination
09/02/2010US20100221810 Novel diglycosidase and gene encoding the same
09/02/2010US20100221807 Cellulase enzyme and method for producing the same
09/02/2010US20100221800 Microorganism engineered to produce isopropanol
09/02/2010US20100221799 Reductase, gene thereof and method of using the same
09/02/2010US20100221791 Method for Incorporating Proteins Into Lentivirus Vectors
09/02/2010US20100221789 HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
09/02/2010US20100221782 Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties
09/02/2010US20100221779 Phytases, nucleic acids encoding them and methods for making and using them
09/02/2010US20100221778 Novel lignin-resistant cellulase enzymes
09/02/2010US20100221777 Designer ligands of tgf-beta superfamily
1 ... 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 ... 4023